Related content

Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian––Caucasian population: differences in enzyme activity

By Serpe Loredana   Calvo Pier Luigi   Muntoni Elisabetta   D’’Antico Sergio   Giaccone Mario   Avagnina Alessandra   Baldi Maurizio   Barbera Cristiana   Curti Franco   Pera Angelo   Eandi Mario   Zara Gian Paolo   Canaparo Roberto  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1753-1765

Future Medicine

Access to resources Recommend Favorite

Clinical Pharmacogenomics of Thiopurine S-methyltransferase

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond

By Karas-Kuzelicki Natasa   Mlinaric-Rascan Irena  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1309-1322

Future Medicine

Access to resources Recommend Favorite

Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms

By  

Current Pharmacogenomics, Vol. 5, Iss. 2, 2007-06 ,pp. : 103-115

Bentham Science Publishers

Access to resources Recommend Favorite

Thiopurine methyltransferase activity in the Jewish population of Israel

By Lowenthal A.   Meyerstein N.   Ben-Zvi Z.  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. : 43-46

Springer Publishing Company

Access to resources Recommend Favorite